loadpatents
name:-0.25304293632507
name:-0.078606843948364
name:-0.0032110214233398
Kruse; Cornelis G. Patent Filings

Kruse; Cornelis G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kruse; Cornelis G..The latest application filed is for "arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists".

Company Profile
0.48.52
  • Kruse; Cornelis G. - CP Weesp NL
  • Kruse; Cornelis G. - Weesp NL
  • Kruse; Cornelis G. - Weep NL
  • Kruse; Cornelis G. - Weeps NL
  • Kruse; Cornelis G - Weesp NL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT.sub.6 antagonists
Grant 9,126,942 - van Loevezijn , et al. September 8, 2
2015-09-08
Arylsulfonyl Pyrazoline Carboxamidine Derivatives As 5-ht6 Antagonists
App 20150051239 - van Loevezijn; Arnold ;   et al.
2015-02-19
Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT.sub.6 antagonists
Grant 8,901,108 - Van Loevezijn , et al. December 2, 2
2014-12-02
Sulfonylpyrazole And Sulfonylpyrazoline Carboxamidine Derivatives As 5-ht6 Antagonists
App 20140303372 - Van Loevezijn; Arnold ;   et al.
2014-10-09
Heterocyclic compounds with affinity to muscarinic receptors
Grant 8,735,388 - Stoit , et al. May 27, 2
2014-05-27
1H-imidazole derivative having CB.sub.1, agonistic, CB.sub.1 partial agonistic or CB.sub.1 antagnistic activity
Grant 8,729,101 - Kruse , et al. May 20, 2
2014-05-20
Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HT.sub.6 antagonists
Grant 8,722,887 - Van Loevezijn , et al. May 13, 2
2014-05-13
Heterocyclic Compounds Iwth Affinity To Muscarinic Receptors
App 20140080861 - Stoit; Axel ;   et al.
2014-03-20
Arylsulfonyl Pyrazoline Carboxamidine Derivatives As 5-ht6 Antagonists
App 20140011775 - van Loevezijn; Arnold ;   et al.
2014-01-09
Heterocyclic compounds with affinity to muscarinic receptors
Grant 8,586,606 - Stoit , et al. November 19, 2
2013-11-19
Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT.sub.6 antagonists
Grant 8,563,723 - Van Loevezijn , et al. October 22, 2
2013-10-22
Sulphur containing pyrazole derivatives as selective cannabinoid CB.sub.1 receptor antagonists
Grant 8,461,184 - Lange , et al. June 11, 2
2013-06-11
Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition
Grant 8,252,930 - Stoit , et al. August 28, 2
2012-08-28
Heterocyclic Compounds With Affinity To Muscarinic Receptors
App 20120095039 - Stoit; Axel ;   et al.
2012-04-19
Compounds with a combination of cannabinoid CB.sub.1 antagonism and serotonin reuptake inhibition
Grant 8,138,174 - Lange , et al. March 20, 2
2012-03-20
Phenylpiperazine derivatives with a combination of partial dopamine-D.sub.2 receptor agonism and serotonin reuptake inhibition
Grant 8,101,619 - Feenstra , et al. January 24, 2
2012-01-24
Heterocyclic compounds with affinity to muscarinic receptors
Grant 8,084,473 - Stoit , et al. December 27, 2
2011-12-27
Compounds with a combination of cannabinoid-CB.sub.1 antagonism and acetylcholinesterase inhibition
Grant 8,063,062 - Lange , et al. November 22, 2
2011-11-22
Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition
Grant 7,964,728 - Stoit , et al. June 21, 2
2011-06-21
Azaindole Derivatives With A Combination Of Partial Nicotinic Acetyl-choline Receptor Agonism And Dopamine Reuptake Inhibition
App 20110053962 - Stoit; Axel ;   et al.
2011-03-03
Arylsulfonyl Pyrazoline Carboxamidine Derivatives As 5-ht6 Antagonists
App 20110046171 - Loevezijn; Arnold Van ;   et al.
2011-02-24
Sulphur Containing Pyrazole Derivatives As Selective Cannabinoid Cb1 Receptor Antagonists
App 20100292204 - Lange; Josephus H.M. ;   et al.
2010-11-18
Sulphur containing pyrazole derivatives as selective cannabinoid CB.sub.1 receptor antagonists
Grant 7,786,144 - Lange , et al. August 31, 2
2010-08-31
Piperazine and piperidine compounds
Grant RE41,425 - Feenstra , et al. July 6, 2
2010-07-06
1,3,5-trisubstituted 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
Grant 7,745,476 - Lange , et al. June 29, 2
2010-06-29
Sulfonylpyrazole And Sulfonylpyrazoline Carboxamidine Derivatives As 5-ht6 Antagonists
App 20100145042 - Van Loevezijn; Arnold ;   et al.
2010-06-10
Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HT.sub.6 antagonists
Grant 7,728,018 - Van Loevezijn , et al. June 1, 2
2010-06-01
Muscarinic Agonists To Treat Impulse Control Disorders
App 20100120752 - De Bruin; Natasja M.W.J. ;   et al.
2010-05-13
N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs
Grant 7,696,383 - Turski , et al. April 13, 2
2010-04-13
4,5-dihydro-1H-pyrazole derivatives having potent CB.sub.1-antagonistic activity
Grant 7,608,718 - Lange , et al. October 27, 2
2009-10-27
Phenylpiperazine
Grant 7,605,162 - Van Hes , et al. October 20, 2
2009-10-20
1h-imidazole Derivative Having Cb1, Agonistic, Cb1 Partial Agonistic Or Cb1 Antagnistic Activity
App 20090181949 - KRUSE; Cornelis G. ;   et al.
2009-07-16
New Phenylpiperazine
App 20090143406 - Hes; Roelof Van ;   et al.
2009-06-04
4,5-dihydro-1H-pyrazole derivatives having CB.sub.1-antagonistic activity
Grant 7,528,162 - Kruse , et al. May 5, 2
2009-05-05
Tetrasubstituted imidazole derivatives as cannabinoid CB.sub.1 receptor modulators with a high CB.sub.1/CB.sub.2 receptor subtype selectivity
Grant 7,524,867 - Lange , et al. April 28, 2
2009-04-28
1 H-imidazole derivatives as cannabinoid receptor modulators
Grant 7,498,348 - Lange , et al. March 3, 2
2009-03-03
Imidazoline derivatives having CB.sub.1-antagonistic activity
Grant 7,495,108 - Lange , et al. February 24, 2
2009-02-24
Heterocyclic Compounds with Affinity to Muscarinic Receptors
App 20090018160 - Stoit; Axel ;   et al.
2009-01-15
Sildenafil N-oxide As Prodrug
App 20090005395 - Turski; Lechoslaw A. ;   et al.
2009-01-01
N-oxides Of Venlafaxine And O-desmethylvenlafaxine As Prodrugs
App 20090005455 - Turski; Lechoslaw A. ;   et al.
2009-01-01
Sulfonylpyrazole And Sulfonylpyrazoline Carboxamidine Derivatives As 5-ht6 Antagonists
App 20080311179 - Van Loevezijn; Arnold ;   et al.
2008-12-18
Phenylpiperazines
Grant 7,456,182 - Van Hes , et al. November 25, 2
2008-11-25
Compounds With A Combination Of Cannabinoid Cb1 Antagonism And Serotonin Reuptake Inhibition
App 20080214559 - Lange; Josephus H.M. ;   et al.
2008-09-04
Use Of 5-ht6 Antagonists To Prevent Relapse Into Addiction
App 20080171779 - De Bruin; Natasja M.W.J. ;   et al.
2008-07-17
Compounds With A Combination Of Cannabinoid-cb1 Antagonism And Acetylcholinesterase Inhibition
App 20080153867 - Lange; Josephus H.M. ;   et al.
2008-06-26
Selective inhibitors of neurotensin degrading enzymes
App 20080146524 - Smid; Pieter ;   et al.
2008-06-19
Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D.sub.2 receptors and serotonin reuptake sites
Grant 7,371,769 - Hes , et al. May 13, 2
2008-05-13
Thiazole derivatives having CB.sub.1-antagonistic, agonistic or partial agonistic activity
Grant 7,342,032 - Lange , et al. March 11, 2
2008-03-11
1H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB.sub.1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activity
Grant 7,319,110 - Lange , et al. January 15, 2
2008-01-15
Azaindole Derivatives With A Combination Of Partial Nicotinic Acetyl-choline Receptor Agonism And Dopamine Reuptake Inhibition
App 20080009514 - STOIT; Axel ;   et al.
2008-01-10
1 H-imidazole Derivatives As Cannabinoid Receptor Modulators
App 20070281974 - Lange; Josephus H.M. ;   et al.
2007-12-06
Sulphur Containing Pyrazole Derivatives As Selective Cannabinoid Cb1 Receptor Antagonists
App 20070281973 - Lange; Josephus H.M. ;   et al.
2007-12-06
Piperazine and piperidine compounds
Grant 7,297,699 - Feenstra , et al. November 20, 2
2007-11-20
Muscarinic Agonists To Treat Impulse Control Disorders
App 20070259859 - De Bruin; Natasja M.W.J. ;   et al.
2007-11-08
4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
App 20070259884 - Lange; Josephus H.M. ;   et al.
2007-11-08
1H-imidazole derivatives as cannabinoid receptor modulators
Grant 7,271,189 - Lange , et al. September 18, 2
2007-09-18
Phenypiperazine Derivatives With A Combination Of Partial Dopamine-d2 Receptor Agonism And Serotonin Reuptake Inhibition
App 20070142397 - Feenstra; Roelof W. ;   et al.
2007-06-21
Imidazoline derivatives having CB1-antagonistic activity
App 20070135492 - Lange; Josephus H.M. ;   et al.
2007-06-14
Neurotensin active 2,3,diaryl-pyrazolidine derivatives
Grant 7,186,741 - Feenstra , et al. March 6, 2
2007-03-06
Imidazoline derivatives having CB.sub.1-antagonistic activity
Grant 7,173,044 - Lange , et al. February 6, 2
2007-02-06
New phenylpiperazines
App 20060293313 - Hes; Roelof Van ;   et al.
2006-12-28
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
App 20060247256 - Feenstra; Roelof W. ;   et al.
2006-11-02
Imidazoline derivatives having CB1-antagonistic activity
App 20060241152 - Lange; Josephus H.M. ;   et al.
2006-10-26
1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
Grant 7,109,216 - Kruse , et al. September 19, 2
2006-09-19
Phenylpiperazines
Grant 7,067,513 - Van Hes , et al. June 27, 2
2006-06-27
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
App 20060122190 - Feenstra; Roelof W. ;   et al.
2006-06-08
Aryloxyethylamine and phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
App 20060122247 - Feenstra; Roelof W. ;   et al.
2006-06-08
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
App 20060122189 - Feenstra; Roelof W. ;   et al.
2006-06-08
Phenylpiperazines with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
App 20060122177 - Hes; Roelof van ;   et al.
2006-06-08
Benzdioxane piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
App 20060122175 - Hes; Roelof van ;   et al.
2006-06-08
Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
App 20060122206 - Hes; Roelof van ;   et al.
2006-06-08
New piperazine and piperidine compounds
App 20060089366 - Feenstra; Roelof W. ;   et al.
2006-04-27
4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
Grant 6,974,810 - Lange , et al. December 13, 2
2005-12-13
Tetrasubstituted imidazole derivatives as cannabinoid CB1 receptor modulators with a high CB1/CB2 receptor subtype selectivity
App 20050267161 - Lange, Josephus H.M. ;   et al.
2005-12-01
Imidazoline derivatives having CB1-antagonistic activity
App 20050187259 - Lange, Josephus H.M. ;   et al.
2005-08-25
1,3,5-trisubstituted 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
App 20050171179 - Lange, Josephus H.M. ;   et al.
2005-08-04
Piperazine and piperidine compounds
Grant 6,911,448 - Feenstra , et al. June 28, 2
2005-06-28
1H-imidazole derivatives as cannabinoid receptor modulators
App 20050137197 - Lange, Josephus H.M. ;   et al.
2005-06-23
Thiazole derivatives as cannabinoid receptor modulators
App 20050065189 - Lange, Josephus H.M. ;   et al.
2005-03-24
1 H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
App 20050054679 - Kruse, Cornelis G. ;   et al.
2005-03-10
Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
App 20040266841 - Lange, Josephus H.M. ;   et al.
2004-12-30
Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
App 20040248944 - Kruse, Cornelis G ;   et al.
2004-12-09
Phenylpiperazines
Grant 6,828,325 - Feenstra , et al. December 7, 2
2004-12-07
Neurotensin active 2,3,diaryl-pyrazolidine derivatives
App 20040242493 - Feenstra, Roelof W. ;   et al.
2004-12-02
1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity
App 20040235854 - Kruse, Cornelis G. ;   et al.
2004-11-25
Piperazine and piperidine compounds
Grant 6,780,864 - Feenstra , et al. August 24, 2
2004-08-24
1H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activity
App 20040106614 - Lange, Josephus H. M. ;   et al.
2004-06-03
4,5-Dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity
App 20040106800 - Lange, Josephus H.M. ;   et al.
2004-06-03
Phenylpiperazines
App 20030162791 - Feenstra, Roelof W ;   et al.
2003-08-28
Piperazine and piperidine compounds
App 20030119849 - Feenstra, Roelof W. ;   et al.
2003-06-26
Benzisoxazole derivatives having d4-antagonistic activity
Grant 6,335,326 - Den Hartog , et al. January 1, 2
2002-01-01
4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
App 20010053788 - Lange, Josephus H. M. ;   et al.
2001-12-20
Bibyclic heteroacrylpiperazine derivatives having psychotropic activity, and pharmaceutical compositions containing these derivatives
Grant 5,424,313 - Hartog , et al. June 13, 1
1995-06-13
Method of treating psychotropic conditions employing substituted piperazine compounds
Grant 4,782,061 - Kruse , et al. November 1, 1
1988-11-01
Phenyl-substituted (N-piperazinyl) methylazoles for treating affections in the central nervous system
Grant 4,772,604 - van Wijngaarden , et al. September 20, 1
1988-09-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed